| Fiscal Q1 Ending 03/13 |
Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
|
Sales/Revenue |
10,412,000 | 7,324,000 | 7,397,000 | 11,002,000 | 11,230,000 |
Cost of Goods Sold (COGS) incl. D&A |
7,090,000 | 5,981,000 | 5,912,000 | 7,831,000 | 7,527,000 |
COGS excluding D&A |
6,657,000 | 5,581,000 | 5,499,000 | 7,386,000 | 7,072,000 |
Depreciation & Amortization Expense |
433,000 | 400,000 | 413,000 | 445,000 | 455,000 |
Gross Income |
3,322,000 | 1,343,000 | 1,485,000 | 3,171,000 | 3,703,000 |
SG&A Expense |
1,504,000 | 1,389,000 | 1,278,000 | 1,714,000 | 1,674,000 |
Research & Development |
521,000 | 547,000 | 506,000 | 528,000 | 505,000 |
Other SG&A |
983,000 | 842,000 | 772,000 | 1,186,000 | 1,169,000 |
Other Operating Expense |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
-80,000 | 153,000 | 157,000 | -241,000 | NA |
Non Operating Income/Expense |
-34,000 | 214,000 | -124,000 | -3,000 | 26,000 |
Equity in Affiliates (Pretax) |
-7,000 | 57,000 | 11,000 | 21,000 | 0 |
Interest Expense |
110,000 | 110,000 | 138,000 | 116,000 | 114,000 |
Gross Interest Expense |
120,000 | 110,000 | 138,000 | 116,000 | 114,000 |
Pretax Income |
1,774,000 | -16,000 | -174,000 | 1,637,000 | 1,941,000 |
Income Tax |
387,000 | -35,000 | -134,000 | 449,000 | 441,000 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 0 |
Consolidated Net Income |
1,387,000 | 19,000 | -40,000 | 1,188,000 | 1,500,000 |
Minority Interest Expense |
7,000 | 1,000 | 3,000 | 9,000 | 12,000 |
Net Income |
1,380,000 | 18,000 | -43,000 | 1,179,000 | 1,488,000 |
Extraordinaries & Discontinued Operations |
1,968,000 | 93,000 | 53,000 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
1,942,000 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
26,000 | 93,000 | 53,000 | NA | NA |
Net Income After Extraordinaries |
-588,000 | -75,000 | -96,000 | 1,179,000 | 1,488,000 |
Preferred Dividends |
3,000 | 2,000 | 3,000 | 2,000 | 0 |
Net Income available to Common |
1,377,000 | 16,000 | -46,000 | 1,177,000 | 1,488,000 |
Operational EPS |
1.41 | 0.13 | 0.07 | 1.07 | 1.58 |
EPS (basic) |
1.51 | 0.12 | 0.01 | 1.26 | 1.59 |
EBITDA |
2,251,000 | 354,000 | 620,000 | 1,902,000 | 2,484,000 |
Depreciation & Amortization Expense |
433,000 | 400,000 | 413,000 | 445,000 | 455,000 |
Common Shares Outstanding |
NA | 942,197 | 940,526 | 942,832 | 944,238 |
Basic Shares Outstanding |
928,348 | 933,275 | 931,737 | 934,057 | 933,910 |
Diluted Shares Outstanding |
935,390 | 942,197 | 940,526 | 942,832 | 944,238 |
Diluted EPS after Extraordinary Items |
3.58 | 0.12 | 0.01 | 1.25 | 1.58 |
Discont. Operations Per Share |
NA | 0.10 | 0.06 | 0 | 0 |
Continued operations EPS |
NA | 0.02 | 0.01 | 1.26 | 1.59 |
*Figures in thousands of U.S. Dollars except shares outstanding.
